Soleus Capital Master Fund, L.P., 10% Owner at Lyra Therapeutics, Inc. (LYRA), bought 524,712 shares at $16.00 ($2.8M) on 2020-05-05, disclosed to the SEC on 2020-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 338,330 | $0 | 0.0% |
| 2 | $8.63 | 31,382 | $271K | 9.8% |
| 3 | $16.00 | 155,000 | $2.5M | 90.2% |
| Total | $5.24 avg | 524,712 | $2.8M | 100% |